Amphotec

This page contains recent news articles, when available, and an overview of Amphotec but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

2008-07-02 20:15:19 - www.companiesandmarkets.com adds new report ...  -  02 Jul 2008
...the company derived majority of its revenues during 2002-2006 from product sales of Actimmune, Infergen, Amphotec and Oritavancin. PR-Inside.com (Pressemitteilung),

Three Rivers Adds Territory of Ireland to Samaritan's Existing ...  -  Oct 11, 2007
The company has continued to expand its product line into the branded market with the acquisition of AMPHOTEC(r)/AMPHOCIL(r) in May of 2005. CNNMoney.com

Lumera Corporation Forms New Bioscience Subsidiary and Initiates ...  -  Jul 17, 2007
Business Wire (press release),...in leading the company to the launch of two products including Amphotec® and Doxil®, a cancer therapeutic, which is now a $400+ million product.

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.